Your browser doesn't support javascript.
loading
Proton-driven transformable nanovaccine for cancer immunotherapy.
Gong, Ningqiang; Zhang, Yuxuan; Teng, Xucong; Wang, Yongchao; Huo, Shuaidong; Qing, Guangchao; Ni, Qiankun; Li, Xianlei; Wang, Jinjin; Ye, Xiaoxia; Zhang, Tingbin; Chen, Shizhu; Wang, Yongji; Yu, Jie; Wang, Paul C; Gan, Yaling; Zhang, Jinchao; Mitchell, Michael J; Li, Jinghong; Liang, Xing-Jie.
  • Gong N; Department of Chemistry, Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Tsinghua University, Beijing, China.
  • Zhang Y; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Teng X; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
  • Wang Y; University of Chinese Academy of Sciences, Beijing, China.
  • Huo S; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Qing G; University of Chinese Academy of Sciences, Beijing, China.
  • Ni Q; Department of Chemistry, Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Tsinghua University, Beijing, China.
  • Li X; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Wang J; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Ye X; Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Science, Xiamen University, Xiamen, China.
  • Zhang T; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Chen S; Department of Chemistry, Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Tsinghua University, Beijing, China.
  • Wang Y; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Yu J; University of Chinese Academy of Sciences, Beijing, China.
  • Wang PC; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Gan Y; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang J; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Mitchell MJ; University of Chinese Academy of Sciences, Beijing, China.
  • Li J; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
  • Liang XJ; Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
Nat Nanotechnol ; 15(12): 1053-1064, 2020 12.
Article en En | MEDLINE | ID: mdl-33106640
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Preparaciones de Acción Retardada / Nanosferas / Antígenos / Neoplasias Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Preparaciones de Acción Retardada / Nanosferas / Antígenos / Neoplasias Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article